200 related articles for article (PubMed ID: 25184545)
1. The disaccharide moiety of bleomycin facilitates uptake by cancer cells.
Schroeder BR; Ghare MI; Bhattacharya C; Paul R; Yu Z; Zaleski PA; Bozeman TC; Rishel MJ; Hecht SM
J Am Chem Soc; 2014 Oct; 136(39):13641-56. PubMed ID: 25184545
[TBL] [Abstract][Full Text] [Related]
2. Selective tumor cell targeting by the disaccharide moiety of bleomycin.
Yu Z; Schmaltz RM; Bozeman TC; Paul R; Rishel MJ; Tsosie KS; Hecht SM
J Am Chem Soc; 2013 Feb; 135(8):2883-6. PubMed ID: 23379863
[TBL] [Abstract][Full Text] [Related]
3. Structural features facilitating tumor cell targeting and internalization by bleomycin and its disaccharide.
Yu Z; Paul R; Bhattacharya C; Bozeman TC; Rishel MJ; Hecht SM
Biochemistry; 2015 May; 54(19):3100-9. PubMed ID: 25905565
[TBL] [Abstract][Full Text] [Related]
4. A gulose moiety contributes to the belomycin (BLM) disaccharide selective targeting to lung cancer cells.
Zhou C; Ye W; Cao Y; Wang M; Qi D; Liao G; Li H; Huang W; Chen W; Wang X; Zhou W
Eur J Med Chem; 2021 Dec; 226():113866. PubMed ID: 34619466
[TBL] [Abstract][Full Text] [Related]
5. Deglycobleomycin A6 analogues modified in the methylvalerate moiety.
Cai X; Zaleski PA; Cagir A; Hecht SM
Bioorg Med Chem; 2011 Jun; 19(12):3831-44. PubMed ID: 21612932
[TBL] [Abstract][Full Text] [Related]
6. Modified bleomycin disaccharides exhibiting improved tumor cell targeting.
Madathil MM; Bhattacharya C; Yu Z; Paul R; Rishel MJ; Hecht SM
Biochemistry; 2014 Nov; 53(43):6800-10. PubMed ID: 25272367
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the selectivity of DNA cleavage by a deglycobleomycin analogue containing a trithiazole moiety.
Thomas CJ; McCormick MM; Vialas C; Tao ZF; Leitheiser CJ; Rishel MJ; Wu X; Hecht SM
J Am Chem Soc; 2002 Apr; 124(15):3875-84. PubMed ID: 11942824
[TBL] [Abstract][Full Text] [Related]
8. Solid-phase synthesis and biochemical evaluation of conformationally constrained analogues of deglycobleomycin A5.
Cagir A; Tao ZF; Sucheck SJ; Hecht SM
Bioorg Med Chem; 2003 Nov; 11(23):5179-87. PubMed ID: 14604681
[TBL] [Abstract][Full Text] [Related]
9. Characterization of bleomycin cleavage sites in strongly bound hairpin DNAs.
Giroux RA; Hecht SM
J Am Chem Soc; 2010 Dec; 132(47):16987-96. PubMed ID: 21047076
[TBL] [Abstract][Full Text] [Related]
10. A designer bleomycin with significantly improved DNA cleavage activity.
Huang SX; Feng Z; Wang L; Galm U; Wendt-Pienkowski E; Yang D; Tao M; Coughlin JM; Duan Y; Shen B
J Am Chem Soc; 2012 Aug; 134(32):13501-9. PubMed ID: 22831455
[TBL] [Abstract][Full Text] [Related]
11. The carbamoylmannose moiety of bleomycin mediates selective tumor cell targeting.
Bhattacharya C; Yu Z; Rishel MJ; Hecht SM
Biochemistry; 2014 May; 53(20):3264-6. PubMed ID: 24811347
[TBL] [Abstract][Full Text] [Related]
12. Conformationally constrained analogues of bleomycin A5.
Rishel MJ; Thomas CJ; Tao ZF; Vialas C; Leitheiser CJ; Hecht SM
J Am Chem Soc; 2003 Aug; 125(34):10194-205. PubMed ID: 12926941
[TBL] [Abstract][Full Text] [Related]
13. Bleomycin analogues preferentially cleave at the transcription start sites of actively transcribed genes in human cells.
Chen JK; Yang D; Shen B; Murray V
Int J Biochem Cell Biol; 2017 Apr; 85():56-65. PubMed ID: 28167289
[TBL] [Abstract][Full Text] [Related]
14. Genome Mining of Streptomyces mobaraensis DSM40847 as a Bleomycin Producer Providing a Biotechnology Platform To Engineer Designer Bleomycin Analogues.
Hindra ; Yang D; Teng Q; Dong LB; Crnovčić I; Huang T; Ge H; Shen B
Org Lett; 2017 Mar; 19(6):1386-1389. PubMed ID: 28256838
[TBL] [Abstract][Full Text] [Related]
15. Biochemical evaluation of a 108-member deglycobleomycin library: viability of a selection strategy for identifying bleomycin analogues with altered properties.
Ma Q; Xu Z; Schroeder BR; Sun W; Wei F; Hashimoto S; Konishi K; Leitheiser CJ; Hecht SM
J Am Chem Soc; 2007 Oct; 129(41):12439-52. PubMed ID: 17887752
[TBL] [Abstract][Full Text] [Related]
16. The genome-wide sequence specificity of DNA cleavage by bleomycin analogues in human cells.
Murray V; Chen JK; Yang D; Shen B
Bioorg Med Chem; 2018 Aug; 26(14):4168-4178. PubMed ID: 30006142
[TBL] [Abstract][Full Text] [Related]
17. Efficient nuclear DNA cleavage in human cancer cells by synthetic bleomycin mimics.
Li Q; van der Wijst MG; Kazemier HG; Rots MG; Roelfes G
ACS Chem Biol; 2014 Apr; 9(4):1044-51. PubMed ID: 24527883
[TBL] [Abstract][Full Text] [Related]
18. [Derivative of bleomycin generates less of ROS? Less of fibrosis? Alternative in the development of an efficacy anticancer therapy but less toxic].
Brahim S; Bettaieb A; Kenani A
Bull Cancer; 2010 May; 97(5):527-34. PubMed ID: 20100681
[TBL] [Abstract][Full Text] [Related]
19. Solid-phase synthesis of deglycobleomycins: a C-terminal tetraamine linker that permits direct evaluation of resin-bound bleomycins.
Tao ZF; Leitheiser CJ; Smith KL; Hashimoto S; Hecht SM
Bioconjug Chem; 2002; 13(3):426-34. PubMed ID: 12009930
[TBL] [Abstract][Full Text] [Related]
20. Zorbamycin has a different DNA sequence selectivity compared with bleomycin and analogues.
Chen JK; Yang D; Shen B; Neilan BA; Murray V
Bioorg Med Chem; 2016 Nov; 24(22):6094-6101. PubMed ID: 27745992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
